Viking Therapeutics, Inc. (NASDAQ:VKTX) Moves into Overbought Territory

Viking Therapeutics, Inc. (NASDAQ:VKTX) shares have moved into overbought range as the 14-day RSI reading reached 83.05 after the recent close. Investors should be cautious of taking positions as this might indicate the stock is due to reverse course.  With Viking Therapeutics, Inc. (NASDAQ:VKTX) shares passing the 70 level, the stock is now considered to be in overbought territory and ripe for a potential pullback.

Viking Therapeutics, Inc. (NASDAQ:VKTX) shares have traded 31.03% for the week and are 91.60% for the year. At the time of writing, the stock is trading at $2.28, a change of 1.33% from the previous close. In terms of volatility, the average daily high/low percentage range stands at 11.92% for the week and 12.09% for the month.

So, most importantly, where are shares headed from here? In order to get a sense of Wall Street sentiment, we can look to brokerage analyst estimates. On a one to five ratings scale where 1.0 indicates a Strong Buy, 2.0 indicates a Buy, 3.0 a Hold, 4.0 a Sell and 5.0 a Stong Sell. Viking Therapeutics, Inc. currently has an average analyst recommendation of 2.00 according to analysts. This is the average number based on the total brokerage firms taken into consideration by Beta Systems Research. The same analysts have a future one-year price target of $6.00 on the shares.

Technical Indicators

In addition to sell-side rational, we can also take a look at some technical indicators. The stock is currently 83.01% away from its 50-day simple moving average and 77.66% away from the 200 day average. Based on a recent trade, the shares are -6.56% away from the 52-week high and 159.09% from the 52-week low. 

Leave a Comment